Newly Released Funding Opportunity - SBIR Program Contract Solicitation (PHS 2018 - 1)

The National Heart, Lung, and Blood Institute sent this bulletin at 07/18/2017 06:25 PM EDT

Office of Translational Alliances and Coordination

SBIR Program Contract Solicitation

PHS 2018-1

Deadline October 20, 2017, 5:00PM ET

The National Heart, Lung, and Blood Institute invites small business concerns to submit research proposals under the Small Business Innovation Research (SBIR) Contract Solicitation. Firms with the capability to conduct research and development (R&D) in any of the health-related topic areas below and to commercialize the results of that R&D, are encouraged to participate.

Devices for Transcatheter Surgery
Tapered Guidewires for Transcatheter Electrosurgery
Reagent Development for Small Cell Number ChIC-seq

There will be a pre-proposal webinar:

Tuesday, August 15, 2017 at 2:00PM ET

Register HERE

For more information on how to apply, please read the full Notice: NOT-OD-17-089

The NHLBI SBIR/STTR Programs provide support for small businesses developing and commercializing novel technologies and products to prevent, diagnose and treat heart, lung, blood, and sleep diseases and disorders. The NHLBI provides grant and contract funding for research and development of technologies related to the mission of NHLBI. For more information about the NHLBI SBIR/STTR Program, including funding opportunities, visit our web page.

NHLBI Small Biz Inquiry Form @NHLBI_SBIR

Manage Subscriptions or Account Preferences | Delete Account | Help

The "Delete Account" link will unsubscribe you from every topic and delete your email address from the system. To unsubscribe from select topics, click on "Manage Subscriptions or Account Preferences."

If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. If you have questions or comments about other NHLBI programs or activities, please contact http://bit.ly/SmallBizInquiry.

This service is provided to you at no charge by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.